2017
DOI: 10.1128/genomea.00551-17
|View full text |Cite
|
Sign up to set email alerts
|

First Draft Genome Sequence of a Clinical Strain of Nocardia cerradoensis

Abstract: This paper reports the first draft genome sequence for a strain of Nocardia cerradoensis obtained from an immunocompetent patient with a knee infection. The 8.2-Mb genome has 8,329 coding sequences, including intrinsic resistance genes, biosynthetic gene clusters for polyketide synthase and nonribosomal peptide synthase, virulence genes, and prophages.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Reports involving studies on the whole genome sequence (WGS) also provided insights into the molecular basis of resistance towards different antibiotics exhibited by different species of Nocardia [22][23][24][25]. Studies on the WGSs of N. cyriacigeorgica strains helped in understanding the physiology, evolution and adaptation of the environmental bacteria for being converted into a pathogenic one [26,27].Genome based analysis of different species of Nocardia revealed some of them to harbour genes responsible for the production of important secondary metabolites like polyketide synthase (PKS-I) and non-ribosomal peptide synthetases (NRPS) [28,29]. Species belonging to the genus Nocardia were also reported to produce valuable metabolites like antibacterial compounds, UVprotectant molecules, immune suppressant, nocavionin and nocobactin derivatives with anti muscarinic activities [30][31][32][33].…”
Section: Introductionmentioning
confidence: 99%
“…Reports involving studies on the whole genome sequence (WGS) also provided insights into the molecular basis of resistance towards different antibiotics exhibited by different species of Nocardia [22][23][24][25]. Studies on the WGSs of N. cyriacigeorgica strains helped in understanding the physiology, evolution and adaptation of the environmental bacteria for being converted into a pathogenic one [26,27].Genome based analysis of different species of Nocardia revealed some of them to harbour genes responsible for the production of important secondary metabolites like polyketide synthase (PKS-I) and non-ribosomal peptide synthetases (NRPS) [28,29]. Species belonging to the genus Nocardia were also reported to produce valuable metabolites like antibacterial compounds, UVprotectant molecules, immune suppressant, nocavionin and nocobactin derivatives with anti muscarinic activities [30][31][32][33].…”
Section: Introductionmentioning
confidence: 99%